Norwegian version of this page

PharmaTox

The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.

PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.

The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.

News

  • img_6563 PharmaTox New Year Kick Off Feb. 16, 2018 11:10 AM

    On February 15, PharmaTox arranged a New Year Kick Off!

  • colourbox8996764 New PharmaTox article in the Biochemical Journal Jan. 19, 2018 12:56 PM

    Read more about the new article "Propionate enters GABAergic neurons, inhibits GABA transaminase, causes GABA accumulation and lethargy in a model of propionic acidemia".

  • cecilie_morland_pechakucha PechaKucha by Cecilie Morland Jan. 18, 2018 9:29 AM

    “Do you get smarter from exercise?”

  • thumb_img_0741_1024 PharmaTox at health data seminar Jan. 11, 2018 11:14 AM

    On January 10, 2018, The faculty of Mathematics and Natural Sciences at UiO arranged a seminar on the value of health data. At the seminar, Hedvig and Geir Kjetil gave a great presentation of PharmaTox, and some examples of the work we do.

  • colourbox7830118 Mollie Wood in Titan Jan. 11, 2018 11:02 AM

    Health data - Norway’s most valuable asset!

Tags: Neurotoxicology, Neuroscience, Pharmacy, Toxicology, Bioinformatics, Biostatistics, Epigenetics
Published Feb. 24, 2015 6:17 PM - Last modified Jan. 5, 2018 2:47 PM

Contact

Leader

Professor
Hedvig Nordeng
(School of Pharmacy)

Leader team

Professor
Ragnhild Paulsen 
(School of Pharmacy)

Associate Professor 
Geir Kjetil Sandve 
(Department of Informatics)

Principal Investigator
Ragnhild Eskeland
(Department of Biosciences)

Professor
Sven Ove Samuelsen
(Department of Mathematics)

Senior researcher
Robert Lyle
(School of Pharmacy)